Persistence of high-level (1,3)-β-D-glucan after candidemia following autologous peripheral SCT in a pediatric patient

Bone Marrow Transplant. 2015 Jan;50(1):137-8. doi: 10.1038/bmt.2014.206. Epub 2014 Sep 22.

Authors

A Naselli¹, M Faraci², E Lanino², G Morreale², G Cangemi³, R Bandettini³, E Castagnola¹

Affiliations

¹ Infectious Diseases Unit, Istituto Giannina Gaslini-Ospedale Pediatrico IRCCS, Genova, Italy.
² Hemopoietic Stem Cell Transplant Unit, Istituto Giannina Gaslini-Ospedale Pediatrico IRCCS, Genova, Italy.
³ Laboratory of Analysis, Istituto Giannina Gaslini-Ospedale Pediatrico IRCCS, Genova, Italy.

PMID: 25243625
DOI: 10.1038/bmt.2014.206

No abstract available

Publication types

Clinical Trial
Letter

MeSH terms

Autografts
Candidiasis* / blood
Candidiasis* / drug therapy
Candidiasis* / etiology
Child
Female
Humans
Medulloblastoma* / blood
Medulloblastoma* / therapy
Peripheral Blood Stem Cell Transplantation
beta-Glucans / blood*

Substances

beta-Glucans
beta-1,3-glucan